Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Mar 23;12(6):4742-4756.
doi: 10.18632/aging.102825. Epub 2020 Mar 23.

Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease

Affiliations

Genome-wide association study identifies genetic factors that modify age at onset in Machado-Joseph disease

Fulya Akçimen et al. Aging (Albany NY). .

Abstract

Machado-Joseph disease (MJD/SCA3) is the most common form of dominantly inherited ataxia worldwide. The disorder is caused by an expanded CAG repeat in the ATXN3 gene. Past studies have revealed that the length of the expansion partly explains the disease age at onset (AO) variability of MJD, which is confirmed in this study (Pearson's correlation coefficient R2 = 0.62). Using a total of 786 MJD patients from five different geographical origins, a genome-wide association study (GWAS) was conducted to identify additional AO modifying factors that could explain some of the residual AO variability. We identified nine suggestively associated loci (P < 1 × 10-5). These loci were enriched for genes involved in vesicle transport, olfactory signaling, and synaptic pathways. Furthermore, associations between AO and the TRIM29 and RAG genes suggests that DNA repair mechanisms might be implicated in MJD pathogenesis. Our study demonstrates the existence of several additional genetic factors, along with CAG expansion, that may lead to a better understanding of the genotype-phenotype correlation in MJD.

Keywords: ATXN3; GWAS; Machado-Joseph disease; age at onset; modifier.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST: The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The inverse correlation between CAGexp and AO (left) and the distribution of residual AO (right) observed in our MJD cohort.
Figure 2
Figure 2
Manhattan plot of the GWAS for residual AO of MJD. Imputed using the HRC panel, 6,716,580 variants that passed QC are included in the plot. The x-axis shows the physical position along the genome. The y-axis shows the −log10(p-value) for association. The red line indicates the level of genome-wide suggestive association (P = 1 × 10−5).
Figure 3
Figure 3
Visualization of the gene-sets and pathways enriched in primary GSEA analysis (A) and replicated in VEGAS and PASCAL (B). The size of the nodes corresponds to the number of the genes associated with a term. The significance is represented by the color of the nodes (P < 0.05, 0.05 < P < 0.1 and P > 0.1 are represented by red, yellow and gray, respectively).

References

    1. Twist EC, Casaubon LK, Ruttledge MH, Rao VS, Macleod PM, Radvany J, Zhao Z, Rosenberg RN, Farrer LA, Rouleau GA. Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. J Med Genet. 1995; 32:25–31. 10.1136/jmg.32.1.25 - DOI - PMC - PubMed
    1. Bettencourt C, Lima M. Machado-Joseph Disease: from first descriptions to new perspectives. Orphanet J Rare Dis. 2011; 6:35. 10.1186/1750-1172-6-35 - DOI - PMC - PubMed
    1. Maciel P, Gaspar C, DeStefano AL, Silveira I, Coutinho P, Radvany J, Dawson DM, Sudarsky L, Guimarães J, Loureiro JE, et al.. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet. 1995; 57:54–61. - PMC - PubMed
    1. de Mattos EP, Kolbe Musskopf M, Bielefeldt Leotti V, Saraiva-Pereira ML, Jardim LB. Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2019; 90:203–10. 10.1136/jnnp-2018-319200 - DOI - PubMed
    1. Zijlstra MP, Rujano MA, Van Waarde MA, Vis E, Brunt ER, Kampinga HH. Levels of DNAJB family members (HSP40) correlate with disease onset in patients with spinocerebellar ataxia type 3. Eur J Neurosci. 2010; 32:760–70. 10.1111/j.1460-9568.2010.07352.x - DOI - PubMed

Publication types